Clinical Trials Browser

INDUSTRY × Carcinoma, Non-Small-Cell Lung × pazopanib × Clear all

NCT02009449 2024-11-15

IVY

Phase 1 Completed

BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT00619424 2017-11-17

A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung

NCT00866528 2017-11-13

Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung Cancer

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung

NCT00549328 2014-11-19

Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer

Phase 2 Terminated

14 enrolled 5 charts

Carcinoma, Non-Small-Cell Lung

NCT00871403 2013-06-20

Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer

Phase 2 Completed

107 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT00367679 2012-06-12

Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer

Phase 2 Completed

35 enrolled 13 charts

Carcinoma, Non-Small-Cell Lung